The efficacy and safety of rivaroxaban after transcatheter aortic valve replacement

Findings from the GALILEO trial comparing rivaroxaban to antiplatelet treatment after successful transcatheter aortic valve replacement.
Findings from the GALILEO trial comparing rivaroxaban to antiplatelet treatment after successful transcatheter aortic valve replacement.